Get startedLog in
    Picture of Aquestive Therapeutics logo

    AQST — Aquestive Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapMomentum Trap
    All News

    Brief: Aquestive Therapeutics Reports Positive Results From Latest Clinical Studies Evaluating Pharmacokinetic And Pharmacodynamic Performance Of Anaphylm ™ (Epinephrine) Sublingual Film And Provides Findings From Recent Auto-Injector Clinical Study

    Picture of Aquestive Therapeutics logoAquestive Therapeutics
    31/05/2023 13:12
    May 31 (Reuters) - Aquestive Therapeutics Inc  AQST.O :
    * AQUESTIVE THERAPEUTICS REPORTS POSITIVE RESULTS FROM
LATEST
CLINICAL STUDIES EVALUATING PHARMACOKINETIC AND PHARMACODYNAMIC
PERFORMANCE OF ANAPHYLM ™ (EPINEPHRINE) SUBLINGUAL FILM AND
PROVIDES FINDINGS FROM RECENT AUTO-INJECTOR CLINICAL STUDY
    * AQUESTIVE THERAPEUTICS INC - CONTINUES TO EXPECT TO SUBMIT
PROTOCOL FOR PIVOTAL STUDY TO FDA IN Q3 2023
    * AQUESTIVE THERAPEUTICS - THERE WERE NO SIGNIFICANT ADVERSE
EVENTS REPORTED DURING STUDY, ANAPHYLM CONTINUES TO BE SAFE AND
WELL-TOLERATED BY SUBJECTS

Source text for Eikon:  ID:nGNX5V2tth 
Further company coverage:  AQST.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Aquestive Therapeutics

    See all news